| 米非司酮对子宫肌瘤患者血清hs-CRP的影响 |
| |
| 引用本文： | 周伟,辛华,杨绿舜,林欢.米非司酮对子宫肌瘤患者血清hs-CRP的影响[J].中国医药导报,2010,7(16):89-90. |
| |
| 作者姓名： | 周伟 辛华 杨绿舜 林欢 |
| |
| 作者单位： | 1. 广东省深圳市宝安区西乡人民医院,广东深圳,518102
2. 广东省深圳市宝安区妇幼保健医院,广东深圳,518101 |
| |
| 摘 要： | 目的：观察子宫肌瘤患者服用米非司酮治疗后,血清高敏C-反应蛋白（hs-CRP）浓度的改变,探讨米非司酮对子宫肌瘤患者的疗效。方法：应用散射比浊法测定100例子宫肌瘤患者经米非司酮治疗后的hs-CRP浓度,并与治疗前进行比较。结果：子宫肌瘤患者hs-CRP浓度水平总体高于正常人,米非司酮治疗子宫肌瘤患者前后的hs-CRP浓度比较,差异有统计学意义（P〈0.01）。结论：子宫肌瘤患者经米非司酮治疗后的hs-CRP浓度明显减低,hs-CRP可作为米非司酮治疗子宫肌瘤的有效指标之一,米非司酮是一种有效、安全的治疗子宫肌瘤的药物。
|
| 关 键 词： | 米非司酮 hs-CRP 子宫肌瘤 |
Influence on Mifepristone in hysteromyoma patients' hs-CRP |
| |
| ZHOU Wei,XIN Hua,YANG Lushun,LIN Huan.Influence on Mifepristone in hysteromyoma patients' hs-CRP[J].China Medical Herald,2010,7(16):89-90. |
| |
| Authors: | ZHOU Wei XIN Hua YANG Lushun LIN Huan |
| |
| Institution: | 1.Xixiang People＇s Hospital,Bao＇an District of Shenzhen,Shenzhen 518102,China;2.Maternity and Child Care Hospitals,Bao＇an District of Shenzhen,Shenzhen 518101,China) |
| |
| Abstract: | Objective：To observe the hs-CRP concentration after Mifepristone in the treatment of hysteromyoma and discuss the effect of Mifepristone in the treatment of hysteromyoma. Methods：We detected 100 cases of hysteromyoma patients＇ hs-CRP concentration by Nephelometry after Mifepristone treatment and compared with before treatment. Results：The hysteromyoma patients＇ hs-CRP level was higher than normal,the difference of patients＇ hs-CRP levels was statistically significant before and after Mifepristone in the treatment of hysteromyoma（P〈0.01） . Conclusion：Hysteromyoma patients＇ hs-CRP concentration after Mifepristone treatment is significantly reduce,hs-CRP as one of the effective index of Mifepristone in the treatment of uterine fibroids,Mifepristone is an effective and safe drug for hysteromyoma. |
| |
| Keywords: | hs-CRP |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
